Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
Status: ENROLLING_BY_INVITATION
Study type: INTERVENTIONAL
Conditions: Ovarian Cancer|Breast Cancer
Interventions: DRUG: Olaparib
Sponsor: AstraZeneca